| Detected | Trial | Change |
|---|---|---|
| 2026-06-05 | NCT04297683 HEALEY ALS Platform Trial - Master Protocol |
Trial sites expanded: 78 -> 81 locations |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT07215949 | Zilucoplan for Severe gMG Exacerbations | Generalized Myasthenia Gravis (gMG) | Recruiting |
| NCT04225871 | Open-Label Extension of Zilucoplan in Subjects With Generalized Myasthenia Gravis | Generalized Myasthenia Gravis | Active, Not Recruiting |
| NCT06435312 | An Open-label Extension Study to Evaluate Subcutaneous Zilucoplan in Pediatric… | Generalized Myasthenia Gravis | Enrolling by Invitation |
| Phase 2/3 | |||
| NCT06055959 | A Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized… | Generalized Myasthenia Gravis | Recruiting |
| NCT04297683 | HEALEY ALS Platform Trial - Master Protocol | Amyotrophic Lateral Sclerosis | Recruiting |
| Phase 1 | |||
| NCT06961747 | A Study to Assess Zilucoplan Concentration in Breast Milk of Healthy Lactating Women | Healthy Participants | Recruiting |